Literature DB >> 32709431

The association between state Medicaid expansion and human papillomavirus vaccination.

Brandon M Hoff1, Melvin D Livingston2, Erika L Thompson3.   

Abstract

Increased vaccination against human papillomavirus (HPV) is recommended to reduce the incidence of anogenital and oropharyngeal cancers. This study aims to evaluate the impact of Medicaid expansion by states on HPV vaccination uptake among adolescents ages 13-17 in the United States. This study analyzed data from the National Immunization Survey (NIS) - Teen from 2011 to 2017 using a cross-sectional design. The adjusted difference-in-difference estimate of Medicaid expansion on HPV vaccine initiation was statistically significant (β = 0.031, 95% CI [0.016, 0.046]). There were significant increases in HPV vaccination after states expanded their Medicaid program. The largest increase occurred in those individuals below the federal poverty level and a modest increase occurred in those above the federal poverty level but below $75,000 of annual family income. Further research should be conducted to analyze the combined effect of multiple policies on HPV vaccination.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Human papillomavirus; Medicaid; Policy

Mesh:

Substances:

Year:  2020        PMID: 32709431     DOI: 10.1016/j.vaccine.2020.07.024

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  3 in total

1.  School-entry requirements for HPV vaccination: part of the patchwork for HPV-related cancer prevention.

Authors:  Erika L Thompson; Ellen M Daley; Tricia Washburn; Kim Salisbury-Keith; Debbie Saslow; Holly B Fontenot; Gregory D Zimet
Journal:  Hum Vaccin Immunother       Date:  2020-12-17       Impact factor: 3.452

2.  Levels of Parental Human Papillomavirus Vaccine Hesitancy and Their Reasons for Not Intending to Vaccinate: Insights From the 2019 National Immunization Survey-Teen.

Authors:  Anne F Rositch; Tanxin Liu; Christina Chao; Meghan Moran; Anna L Beavis
Journal:  J Adolesc Health       Date:  2022-03-09       Impact factor: 7.830

3.  Adherence to the Recommended HPV Vaccine Dosing Schedule among Adolescents Aged 13 to 17 Years: Findings from the National Immunization Survey-Teen, 2019-2020.

Authors:  Chinenye Lynette Ejezie; Ikponmwosa Osaghae; Sylvia Ayieko; Paula Cuccaro
Journal:  Vaccines (Basel)       Date:  2022-04-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.